These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24497578)

  • 1. Association of polyalanine and polyglutamine coiled coils mediates expansion disease-related protein aggregation and dysfunction.
    Pelassa I; Corà D; Cesano F; Monje FJ; Montarolo PG; Fiumara F
    Hum Mol Genet; 2014 Jul; 23(13):3402-20. PubMed ID: 24497578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyserine repeats promote coiled coil-mediated fibril formation and length-dependent protein aggregation.
    Lilliu E; Villeri V; Pelassa I; Cesano F; Scarano D; Fiumara F
    J Struct Biol; 2018 Dec; 204(3):572-584. PubMed ID: 30194983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins.
    Fiumara F; Fioriti L; Kandel ER; Hendrickson WA
    Cell; 2010 Dec; 143(7):1121-35. PubMed ID: 21183075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure analysis of the proteins associated with polyA repeat expansion disorders.
    Hernandez R; Facelli JC
    J Biomol Struct Dyn; 2022 Aug; 40(12):5556-5565. PubMed ID: 33459170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between PolyQ and protein context delays aggregation by forming a reservoir of protofibrils.
    Bulone D; Masino L; Thomas DJ; San Biagio PL; Pastore A
    PLoS One; 2006 Dec; 1(1):e111. PubMed ID: 17205115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects.
    Kwon MJ; Han MH; Bagley JA; Hyeon DY; Ko BS; Lee YM; Cha IJ; Kim SY; Kim DY; Kim HM; Hwang D; Lee SB; Jan YN
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10748-E10757. PubMed ID: 30348793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rate of polyQ-mediated aggregation is dramatically affected by the number and location of surrounding domains.
    Robertson AL; Bate MA; Buckle AM; Bottomley SP
    J Mol Biol; 2011 Nov; 413(4):879-87. PubMed ID: 21945530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyglutamine expansion diseases: More than simple repeats.
    Silva A; de Almeida AV; Macedo-Ribeiro S
    J Struct Biol; 2018 Feb; 201(2):139-154. PubMed ID: 28928079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context.
    Jazurek-Ciesiolka M; Ciesiolka A; Komur AA; Urbanek-Trzeciak MO; Krzyzosiak WJ; Fiszer A
    J Mol Biol; 2020 Dec; 432(24):166699. PubMed ID: 33157084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks.
    Schaefer MH; Wanker EE; Andrade-Navarro MA
    Nucleic Acids Res; 2012 May; 40(10):4273-87. PubMed ID: 22287626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal.
    Kandola T; Venkatesan S; Zhang J; Lerbakken BT; Von Schulze A; Blanck JF; Wu J; Unruh JR; Berry P; Lange JJ; Box AC; Cook M; Sagui C; Halfmann R
    Elife; 2023 Nov; 12():. PubMed ID: 37921648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.
    Jayaraman M; Kodali R; Sahoo B; Thakur AK; Mayasundari A; Mishra R; Peterson CB; Wetzel R
    J Mol Biol; 2012 Feb; 415(5):881-99. PubMed ID: 22178474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Length-dependent aggregation of uninterrupted polyalanine peptides.
    Bernacki JP; Murphy RM
    Biochemistry; 2011 Nov; 50(43):9200-11. PubMed ID: 21932820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the treatment of polyglutamine diseases: the modulatory role of protein context.
    Robertson AL; Bottomley SP
    Curr Med Chem; 2010; 17(27):3058-68. PubMed ID: 20629626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.
    Adegbuyiro A; Sedighi F; Pilkington AW; Groover S; Legleiter J
    Biochemistry; 2017 Mar; 56(9):1199-1217. PubMed ID: 28170216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.
    Kubota H; Kitamura A; Nagata K
    Methods; 2011 Mar; 53(3):267-74. PubMed ID: 21195182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and disaggregation of asparagine repeat-containing peptides.
    Lu X; Murphy RM
    J Pept Sci; 2014 Nov; 20(11):860-7. PubMed ID: 25044797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregation of polyQ-extended proteins is promoted by interaction with their natural coiled-coil partners.
    Petrakis S; Schaefer MH; Wanker EE; Andrade-Navarro MA
    Bioessays; 2013 Jun; 35(6):503-7. PubMed ID: 23483542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.
    Meriin AB; Zhang X; He X; Newnam GP; Chernoff YO; Sherman MY
    J Cell Biol; 2002 Jun; 157(6):997-1004. PubMed ID: 12058016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.